Atlas Trials

Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine

Clinical trial NCT02184091 · COMPLETED

Trial details

NCT number
NCT02184091
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal InsufficiencyHepatic Insufficiency
Start date
1999-01-01
Primary completion
1999-07-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.